{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:09:54Z","timestamp":1792300194489,"version":"4.4.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1038\/nrcardio.2009.11","type":"journal-article","created":{"date-parts":[[2009,3,26]],"date-time":"2009-03-26T00:53:00Z","timestamp":1238028780000},"page":"301-311","source":"Crossref","is-referenced-by-count":107,"title":["Cardiovascular implications of proteinuria: an indicator of chronic kidney disease"],"prefix":"10.1038","volume":"6","author":[{"given":"Varun","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Marinescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnrcardio200911_CR1","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","volume":"108","author":"MJ Sarnak","year":"2003","unstructured":"Sarnak, M. J.  et al. American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108, 2154\u20132169 (2003).","journal-title":"Circulation"},{"key":"BFnrcardio200911_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1053\/j.ajkd.2007.06.013","volume":"50","author":"JA Vassalotti","year":"2007","unstructured":"Vassalotti, J. A., Stevens, L. A. & Levey, A. S. Testing for chronic kidney disease: a position statement from the National Kidney Foundation. Am. J. Kidney Dis. 50, 169\u2013180 (2007).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrcardio200911_CR3","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1046\/j.1523-1755.2002.00356.x","volume":"61","author":"AX Garg","year":"2002","unstructured":"Garg, A. X., Kiberd, B. A., Clark, W. F., Haynes, R. B. & Clase, C. M. Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. Kidney Int. 61, 2165\u20132175 (2002).","journal-title":"Kidney Int."},{"key":"BFnrcardio200911_CR4","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1111\/j.1523-1755.2004.09212.x","volume":"92","author":"J Segura","year":"2004","unstructured":"Segura, J., Campo, C. & Ruilope, L. M. Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension. Kidney Int. Suppl. 92, S45\u2013S49 (2004).","journal-title":"Kidney Int. Suppl."},{"key":"BFnrcardio200911_CR5","doi-asserted-by":"publisher","first-page":"581","DOI":"10.2215\/CJN.03190906","volume":"2","author":"MR Weir","year":"2007","unstructured":"Weir, M. R. Microalbuminuria and cardiovascular disease. Clin. J. Am. Soc. Nephrol. 2, 581\u2013590 (2007).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrcardio200911_CR6","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1001\/jama.290.23.3101","volume":"290","author":"LE Boulware","year":"2003","unstructured":"Boulware, L. E., Jaar, B. G., Tarver-Carr, M. E., Brancati, F. L. & Powe, N. R. Screening for proteinuria in US adults: a cost-effectiveness analysis. JAMA 290, 3101\u20133114 (2003).","journal-title":"JAMA"},{"key":"BFnrcardio200911_CR7","unstructured":"National Kidney Foundation. K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 39 (2 Suppl. 1), S1\u2013S266 (2002)."},{"key":"BFnrcardio200911_CR8","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3949\/ccjm.70.6.535","volume":"70","author":"W Kashif","year":"2003","unstructured":"Kashif, W., Siddiqi, N., Dincer, A. P., Dincer, H. E. & Hirsch, S. Proteinuria: how to evaluate an important finding. Cleve. Clin. J. Med. 70, 535\u2013537, 541\u2013544, 546\u2013547 (2003).","journal-title":"Cleve. Clin. J. Med."},{"key":"BFnrcardio200911_CR9","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1681\/ASN.2005101085","volume":"17","author":"M Tonelli","year":"2006","unstructured":"Tonelli, M.  et al. Chronic kidney disease and mortality risk: a systematic review. J. Am. Soc. Nephrol. 17, 2034\u20132047 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrcardio200911_CR10","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1001\/archinte.164.6.659","volume":"164","author":"DS Keith","year":"2004","unstructured":"Keith, D. S., Nichols, G. A., Gullion, C. M., Brown, J. B. & Smith, D. H. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch. Intern. Med. 164, 659\u2013663 (2004).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio200911_CR11","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E. & Hsu, C. Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351, 1296\u20131305 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio200911_CR12","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1159\/000115291","volume":"28","author":"R Agarwal","year":"2008","unstructured":"Agarwal, R., Bunaye, Z., Bekele, D. M. & Light, R. P. Competing risk factor analysis of end-stage renal disease and mortality in chronic kidney disease. Am. J. Nephrol. 28, 569\u2013575 (2008).","journal-title":"Am. J. Nephrol."},{"key":"BFnrcardio200911_CR13","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1161\/01.CIR.0000139860.33974.28","volume":"110","author":"D de Zeeuw","year":"2004","unstructured":"de Zeeuw, D.  et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 110, 921\u2013927 (2004).","journal-title":"Circulation"},{"key":"BFnrcardio200911_CR14","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1056\/NEJM199604113341502","volume":"334","author":"G Maschio","year":"1996","unstructured":"Maschio, G.  et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N. Engl. J. Med. 334, 939\u2013945 (1996).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio200911_CR15","doi-asserted-by":"crossref","unstructured":"[No authors listed.] Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Lancet 349, 1857\u20131863 (1997).","DOI":"10.1016\/S0140-6736(96)11445-8"},{"key":"BFnrcardio200911_CR16","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/ki.1993.292","volume":"44","author":"JD Ordo\u00f1ez","year":"1993","unstructured":"Ordo\u00f1ez, J. D., Hiatt, R. A., Killebrew, E. J. & Fireman, B. H. The increased risk of coronary heart disease associated with nephrotic syndrome. Kidney Int. 44, 638\u2013642 (1993).","journal-title":"Kidney Int."},{"key":"BFnrcardio200911_CR17","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1016\/S0735-1097(03)00403-0","volume":"41","author":"JE Liu","year":"2003","unstructured":"Liu, J. E., Robbins, D. C., Palmieri, V., Bella, J. N., Roman, M. J., Fabsitz, R., Howard, B. V., Welty, T. K., Lee, E. T., Devereux, R. B. Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the Strong Heart Study. J. Am. Coll. Cardiol. 41, 2022\u20132028 (2003).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio200911_CR18","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1161\/01.STR.27.11.2033","volume":"27","author":"H Miettinen","year":"1996","unstructured":"Miettinen, H., Haffner, S. M., Lehto, S., R\u00f6nnemaa, T., Py\u00f6r\u00e4l\u00e4, K., Laakso, M. Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke 27, 2033\u20132039 (1996).","journal-title":"Stroke"},{"key":"BFnrcardio200911_CR19","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1161\/CIRCULATIONAHA.108.772285","volume":"118","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y.  et al. Incidence and risk factors for stroke in American Indians: the Strong Heart Study. Circulation 118, 1577\u20131584 (2008).","journal-title":"Circulation"},{"key":"BFnrcardio200911_CR20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/ndt\/gfg533","volume":"19","author":"AA Eddy","year":"2004","unstructured":"Eddy, A. A. Proteinuria and interstitial injury. Nephrol. Dial. Transplant. 19, 277\u2013281 (2004).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrcardio200911_CR21","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1681\/ASN.2006040377","volume":"17","author":"M Abbate","year":"2006","unstructured":"Abbate, M., Zoja, C. & Remuzzi, G. How does proteinuria cause progressive renal damage? J. Am. Soc. Nephrol. 17, 2974\u20132984 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrcardio200911_CR22","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1111\/j.1523-1755.2005.09906.x","volume":"68","author":"J Fort","year":"2005","unstructured":"Fort, J. Chronic renal failure: a cardiovascular risk factor. Kidney Int. 68, S25\u2013S29 (2005).","journal-title":"Kidney Int."},{"issue":"Suppl. 1","key":"BFnrcardio200911_CR23","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/ndt\/16.suppl_1.70","volume":"16","author":"N Ridao","year":"2001","unstructured":"Ridao, N.  et al. Prevalence of hypertension in renal disease. Nephrol. Dial. Transplant. 16 (Suppl. 1), 70\u201373 (2001).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrcardio200911_CR24","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1291\/hypres.29.687","volume":"29","author":"T Inoue","year":"2006","unstructured":"Inoue, T.  et al. Proteinuria as a significant determinant of hypertension in a normotensive screened cohort in Okinawa, Japan. Hypertens. Res. 29, 687\u2013693 (2006).","journal-title":"Hypertens. Res."},{"key":"BFnrcardio200911_CR25","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1161\/01.HYP.0000178102.85718.66","volume":"46","author":"R Agarwal","year":"2005","unstructured":"Agarwal, R. & Andersen, M. J. Correlates of systolic hypertension in patients with chronic kidney disease. Hypertension 46, 514\u2013520 (2005).","journal-title":"Hypertension"},{"key":"BFnrcardio200911_CR26","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1053\/j.ajkd.2006.01.027","volume":"47","author":"Y Ohya","year":"2006","unstructured":"Ohya, Y.  et al. Increased pulse wave velocity is associated with low creatinine clearance and proteinuria in a screened cohort. Am. J. Kidney Dis. 47, 790\u2013797 (2006).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrcardio200911_CR27","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJMoa011161","volume":"345","author":"BM Brenner","year":"2001","unstructured":"Brenner, B. M.  et al. RENAAL Study. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N. Engl. J. Med. 345, 861\u2013869 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio200911_CR28","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1056\/NEJMoa011303","volume":"345","author":"EJ Lewis","year":"2001","unstructured":"Lewis, E. J.  et al. Collaborative Study Group. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N. Engl. J. Med. 345, 851\u2013860 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio200911_CR29","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1161\/01.HYP.0000137192.19577.c3","volume":"44","author":"WY So","year":"2004","unstructured":"So, W. Y.  et al. Effect of angiotensin-converting enzyme inhibition on survival in 3773 Chinese type 2 diabetic patients. Hypertension 44, 294\u2013299 (2004).","journal-title":"Hypertension"},{"key":"BFnrcardio200911_CR30","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1136\/bmj.37970.629537.0D","volume":"328","author":"M Marre","year":"2004","unstructured":"Marre, M.  et al. DIABHYCAR Study Investigators. Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study). BMJ 328, 495 (2004).","journal-title":"BMJ"},{"key":"BFnrcardio200911_CR31","doi-asserted-by":"crossref","unstructured":"ONTARGET Investigators  et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N. Engl. J. Med. 358, 1547\u20131559 (2008).","DOI":"10.1056\/NEJMoa0801317"},{"key":"BFnrcardio200911_CR32","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0140-6736(08)61236-2","volume":"372","author":"JF Mann","year":"2008","unstructured":"Mann, J. F.  et al. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 372, 547\u2013553 (2008).","journal-title":"Lancet"},{"key":"BFnrcardio200911_CR33","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1053\/j.ajkd.2008.02.297","volume":"52","author":"L Tylicki","year":"2008","unstructured":"Tylicki, L.  et al. Triple pharmacological blockade of the renin\u2013angiotensin\u2013aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial. Am. J. Kidney Dis. 52, 486\u2013493 (2008).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrcardio200911_CR34","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1093\/ndt\/gfn234","volume":"23","author":"KA Barraclough","year":"2008","unstructured":"Barraclough, K. A.  et al. Coronary artery calcification scores in patients with chronic kidney disease prior to dialysis: reliability as a trial outcome measure. Nephrol. Dial. Transplant. 23, 3199\u20133205 (2008).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrcardio200911_CR35","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1093\/ndt\/gfh120","volume":"19","author":"AA Haydar","year":"2004","unstructured":"Haydar, A. A.  et al. Coronary artery calcification is related to coronary atherosclerosis in chronic renal disease patients: a study comparing EBCT-generated coronary artery calcium scores and coronary angiography. Nephrol. Dial. Transplant. 19, 2307\u20132312 (2004).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrcardio200911_CR36","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.2337\/diabetes.49.9.1571","volume":"49","author":"JC Olson","year":"2000","unstructured":"Olson, J. C., Edmundowicz, D., Becker, D. J., Kuller, L. H. & Orchard, T. J. Coronary calcium in adults with type 1 diabetes: a stronger correlate of clinical coronary artery disease in men than in women. Diabetes 49, 1571\u20131578 (2000).","journal-title":"Diabetes"},{"key":"BFnrcardio200911_CR37","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2337\/diabetes.50.4.861","volume":"50","author":"LE Wagenknecht","year":"2001","unstructured":"Wagenknecht, L. E.  et al. Familial aggregation of coronary artery calcium in families with type 2 diabetes. Diabetes 50, 861\u2013866 (2001).","journal-title":"Diabetes"},{"key":"BFnrcardio200911_CR38","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1111\/j.1523-1755.2004.00974.x","volume":"66","author":"R Mehrotra","year":"2004","unstructured":"Mehrotra, R.  et al. Determinants of coronary artery calcification in diabetics with and without nephropathy. Kidney Int. 66, 2022\u20132031 (2004).","journal-title":"Kidney Int."},{"issue":"Suppl. 3","key":"BFnrcardio200911_CR39","doi-asserted-by":"publisher","first-page":"S142","DOI":"10.1053\/ajkd.1998.v32.pm9820472","volume":"32","author":"BL Kasiske","year":"1998","unstructured":"Kasiske, B. L. Hyperlipidemia in patients with chronic renal disease. Am. J. Kidney Dis. 32 (Suppl. 3), S142\u2013S156 (1998).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrcardio200911_CR40","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1161\/01.HYP.0000022805.11288.7F","volume":"40","author":"TM Lee","year":"2002","unstructured":"Lee, T. M., Su, S. F. & Tsai, C. H. Effect of pravastatin on proteinuria in patients with well-controlled hypertension. Hypertension 40, 67\u201373 (2002).","journal-title":"Hypertension"},{"key":"BFnrcardio200911_CR41","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/j.1523-1755.2005.00457.x","volume":"68","author":"TM Lee","year":"2005","unstructured":"Lee, T. M., Lin, M. S., Tsai, C. H. & Chang, N. C. Add-on and withdrawal effect of pravastatin on proteinuria in hypertensive patients treated with AT receptor blockers. Kidney Int. 68, 779\u2013787 (2005).","journal-title":"Kidney Int."},{"key":"BFnrcardio200911_CR42","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1053\/ajkd.2003.50140","volume":"41","author":"S Bianchi","year":"2003","unstructured":"Bianchi, S., Bigazzi, R., Caiazza, A. & Campese, V. M. A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease. Am. J. Kidney Dis. 41, 565\u2013570 (2003).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrcardio200911_CR43","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/BF02342442","volume":"35","author":"E Hommel","year":"1992","unstructured":"Hommel, E.  et al. Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy. Diabetologia 35, 447\u2013451 (1992).","journal-title":"Diabetologia"},{"key":"BFnrcardio200911_CR44","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/ki.1993.358","volume":"44","author":"ME Thomas","year":"1993","unstructured":"Thomas, M. E.  et al. Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria. Kidney Int. 44, 1124\u20131129 (1993).","journal-title":"Kidney Int."},{"key":"BFnrcardio200911_CR45","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/S0140-6736(88)90870-7","volume":"2","author":"AJ Rabelink","year":"1988","unstructured":"Rabelink, A. J., Hen\u00e9, R. J., Erkelens, D. W., Joles, J. A. & Koomans, H. A. Effects of simvastatin and cholestyramine on lipoprotein profile in hyperlipidaemia of nephrotic syndrome. Lancet 2, 1335\u20131338 (1988).","journal-title":"Lancet"},{"key":"BFnrcardio200911_CR46","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1136\/bmj.39472.580984.AE","volume":"336","author":"GF Strippoli","year":"2008","unstructured":"Strippoli, G. F.  et al. Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ 336, 645\u2013651 (2008).","journal-title":"BMJ"},{"key":"BFnrcardio200911_CR47","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1097\/01.ASN.0000143720.71748.79","volume":"15","author":"R Agarwal","year":"2004","unstructured":"Agarwal, R. Statin induced proteinuria: renal injury or renoprotection? J. Am. Soc. Nephrol. 15, 2502\u20132503 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrcardio200911_CR48","doi-asserted-by":"publisher","first-page":"811","DOI":"10.2337\/dc08-9018","volume":"31","author":"JD Brunzell","year":"2008","unstructured":"Brunzell, J. D.  et al. Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care 31, 811\u2013822 (2008).","journal-title":"Diabetes Care"},{"key":"BFnrcardio200911_CR49","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1161\/01.CIR.0000148980.87579.5E","volume":"110","author":"GL Myers","year":"2004","unstructured":"Myers, G. L.  et al. CDC\/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the laboratory science discussion group. Circulation 110, 545\u2013549 (2004).","journal-title":"Circulation"},{"key":"BFnrcardio200911_CR50","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/sj.ki.5001632","volume":"70","author":"K Caglar","year":"2006","unstructured":"Caglar, K.  et al. ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease. Kidney Int. 70, 781\u2013787 (2006).","journal-title":"Kidney Int."},{"key":"BFnrcardio200911_CR51","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1681\/ASN.2007040461","volume":"19","author":"MI Yilmaz","year":"2008","unstructured":"Yilmaz, M. I.  et al. ADMA levels correlate with proteinuria, secondary amyloidosis, and endothelial dysfunction. J. Am. Soc. Nephrol. 19, 388\u2013395 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrcardio200911_CR52","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.2337\/diabetes.51.4.1157","volume":"51","author":"CD Stehouwer","year":"2002","unstructured":"Stehouwer, C. D.  et al. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes 51, 1157\u20131165 (2002).","journal-title":"Diabetes"},{"key":"BFnrcardio200911_CR53","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.2337\/diabetes.52.5.1215","volume":"52","author":"AA Jaffa","year":"2003","unstructured":"Jaffa, A. A.  et al. Plasma prekallikrein: a risk marker for hypertension and nephropathy in type 1 diabetes. Diabetes 52, 1215\u20131221 (2003).","journal-title":"Diabetes"},{"key":"BFnrcardio200911_CR54","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jdiacomp.2005.05.008","volume":"20","author":"K Takebayashi","year":"2006","unstructured":"Takebayashi, K., Matsumoto, S., Aso, Y. & Inukai, T. Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese type 2 diabetic patients. J. Diabetes Complications 20, 98\u2013104 (2006).","journal-title":"J. Diabetes Complications"},{"key":"BFnrcardio200911_CR55","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0168-8227(97)01384-3","volume":"36","author":"T Hirano","year":"1997","unstructured":"Hirano, T., Kashiwazaki, K., Moritomo, Y., Nagano, S. & Adachi, M. Albuminuria is directly associated with increased plasma PAI-1 and factor VII levels in NIDDM patients. Diabetes Res. Clin. Pract. 36, 11\u201318 (1997).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"BFnrcardio200911_CR56","first-page":"230","volume":"46","author":"J Zimmermann","year":"1996","unstructured":"Zimmermann, J.  et al. Hemorheology, plasma protein composition and von Willebrand factor in type I diabetic nephropathy. Clin. Nephrol. 46, 230\u2013236 (1996).","journal-title":"Clin. Nephrol."},{"key":"BFnrcardio200911_CR57","first-page":"H286","volume":"273","author":"MS Blum","year":"1997","unstructured":"Blum, M. S.  et al. Cytoskeletal rearrangement mediates human microvascular endothelial tight junction modulation by cytokines. Am. J. Physiol. 273, H286\u2013;H294 (1997).","journal-title":"Am. J. Physiol."},{"key":"BFnrcardio200911_CR58","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/S0008-6363(96)00064-8","volume":"32","author":"CC Michel","year":"1996","unstructured":"Michel, C. C. Transport of macromolecules through microvascular walls. Cardiovasc. Res. 32, 644\u2013653 (1996).","journal-title":"Cardiovasc. Res."},{"key":"BFnrcardio200911_CR59","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1006\/mvre.2000.2274","volume":"61","author":"SM Vogel","year":"2001","unstructured":"Vogel, S. M.  et al. Evidence of transcellular permeability pathway in microvessels. Microvasc. Res. 61, 87\u2013101 (2001).","journal-title":"Microvasc. Res."},{"key":"BFnrcardio200911_CR60","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1152\/physrev.00047.2003","volume":"84","author":"R Stocker","year":"2004","unstructured":"Stocker, R. & Keaney, J. F. Jr Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84, 1381\u20131478 (2004).","journal-title":"Physiol. Rev."},{"key":"BFnrcardio200911_CR61","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1007\/s001250050619","volume":"39","author":"HH Parving","year":"1996","unstructured":"Parving, H. H.  et al. Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy. Diabetologia 39, 1590\u20131597 (1996).","journal-title":"Diabetologia"},{"key":"BFnrcardio200911_CR62","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1046\/j.1523-1755.2003.00768.x","volume":"63","author":"KE Paisley","year":"2003","unstructured":"Paisley, K. E.  et al. Endothelial dysfunction and inflammation in asymptomatic proteinuria. Kidney Int. 63, 624\u2013633 (2003).","journal-title":"Kidney Int."},{"key":"BFnrcardio200911_CR63","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1161\/01.CIR.97.1.108","volume":"97","author":"RM Wever","year":"1998","unstructured":"Wever, R. M., L\u00fcscher, T. F., Cosentino, F. & Rabelink, T. J. Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation 97, 108\u201312 (1998).","journal-title":"Circulation"},{"key":"BFnrcardio200911_CR64","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0140-6736(95)91322-X","volume":"346","author":"ES Stroes","year":"1995","unstructured":"Stroes, E. S., Koomans, H. A., de Bruin, T. W. & Rabelink, T. J. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet 346, 467\u2013471 (1995).","journal-title":"Lancet"},{"key":"BFnrcardio200911_CR65","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1046\/j.1523-1755.1999.0550031005.x","volume":"55","author":"TD Vuong","year":"1999","unstructured":"Vuong, T. D.  et al. Hypoalbuminemia increases lysophosphatidylcholine in low-density lipoprotein of normocholesterolemic subjects. Kidney Int. 55, 1005\u20131010 (1999).","journal-title":"Kidney Int."},{"key":"BFnrcardio200911_CR66","first-page":"RA5","volume":"12","author":"P Kougias","year":"2006","unstructured":"Kougias, P.  et al. Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis. Med. Sci. Monit. 12, RA5\u2013RA16 (2006).","journal-title":"Med. Sci. Monit."},{"key":"BFnrcardio200911_CR67","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1053\/j.ajkd.2006.11.039","volume":"49","author":"X Zhu","year":"2007","unstructured":"Zhu, X., Wu, S., Dahut, W. L. & Parikh, C. R. Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis. Am. J. Kidney Dis. 49, 186\u2013193 (2007).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrcardio200911_CR68","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa021491","volume":"349","author":"JC Yang","year":"2003","unstructured":"Yang, J. C.  et al. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N. Engl. J. Med. 349, 427\u2013434 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio200911_CR69","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/ki.2008.256","volume":"74","author":"MB Stokes","year":"2008","unstructured":"Stokes, M. B., Erazo, M. C. & D'Agati, V. D. Glomerular disease related to anti-VEGF therapy. Kidney Int. 74, 1487\u20131491 (2008).","journal-title":"Kidney Int."},{"issue":"Suppl","key":"BFnrcardio200911_CR70","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1111\/j.1523-1755.2004.09213.x","volume":"92","author":"NS Anavekar","year":"2004","unstructured":"Anavekar, N. S.  et al. Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: a case for albuminuria. Kidney Int. Suppl 92, S50\u2013S55 (2004).","journal-title":"Kidney Int."},{"key":"BFnrcardio200911_CR71","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1681\/ASN.2005121352","volume":"17","author":"N Halbesma","year":"2006","unstructured":"Halbesma, N.  et al. Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening. J. Am. Soc. Nephrol. 17, 2582\u20132590 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrcardio200911_CR72","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1007\/BF00281993","volume":"28","author":"K Borch-Johnsen","year":"1985","unstructured":"Borch-Johnsen, K., Andersen, P. K. & Deckert, T. The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28, 590\u2013596 (1985).","journal-title":"Diabetologia"},{"key":"BFnrcardio200911_CR73","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1590\/S0100-879X2008000800006","volume":"41","author":"CR Cardoso","year":"2008","unstructured":"Cardoso, C. R. & Salles, G. F. Gross proteinuria is a strong risk predictor for cardiovascular mortality in Brazilian type 2 diabetic patients. Braz. J. Med. Biol. Res. 41, 674\u2013680 (2008).","journal-title":"Braz. J. Med. Biol. Res."},{"key":"BFnrcardio200911_CR74","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/0002-8703(84)90763-4","volume":"108","author":"WB Kannel","year":"1984","unstructured":"Kannel, W. B., Stampfer, M. J., Castelli, W. P. & Verter, J. The prognostic significance of proteinuria: the Framingham study. Am. Heart J. 108, 1347\u20131352 (1984).","journal-title":"Am. Heart J."},{"issue":"3rd","key":"BFnrcardio200911_CR75","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1093\/aje\/kwn033","volume":"167","author":"BC Astor","year":"2008","unstructured":"Astor, B. C., Hallan, S. I., Miller, E. R. 3rd, Yeung, E. & Coresh, J. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am. J. Epidemiol. 167, 1226\u20131234 (2008).","journal-title":"Am. J. Epidemiol."},{"key":"BFnrcardio200911_CR76","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1161\/01.CIR.0000031732.78052.81","volume":"106","author":"HL Hillege","year":"2002","unstructured":"Hillege, H. L.  et al. Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106, 1777\u20131782 (2002).","journal-title":"Circulation"},{"key":"BFnrcardio200911_CR77","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1161\/01.CIR.99.18.2389","volume":"99","author":"BV Howard","year":"1999","unstructured":"Howard, B. V.  et al. Rising tide of cardiovascular disease in American Indians. The Strong Heart Study. Circulation 99, 2389\u20132395 (1999).","journal-title":"Circulation"},{"key":"BFnrcardio200911_CR78","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1177\/14746514050050060701","volume":"5","author":"J Xu","year":"2005","unstructured":"Xu, J.  et al. Association of albuminuria with all-cause and cardiovascular disease mortality in diabetes: the Strong Heart Study. Br. J. Diabetes Vasc. Dis. 5, 334\u2013340 (2005).","journal-title":"Br. J. Diabetes Vasc. Dis."},{"key":"BFnrcardio200911_CR79","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/aje\/kwh037","volume":"159","author":"MF Yuyun","year":"2004","unstructured":"Yuyun, M. F.  et al. A prospective study of microalbuminuria and incident coronary heart disease and its prognostic significance in a British population: the EPIC-Norfolk study. Am. J. Epidemiol. 159, 284\u2013293 (2004).","journal-title":"Am. J. Epidemiol."},{"key":"BFnrcardio200911_CR80","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1111\/j.1523-1755.2005.00526.x","volume":"68","author":"Z Wang","year":"2005","unstructured":"Wang, Z. & Hoy, W. E. Albuminuria and incident coronary heart disease in Australian Aboriginal people. Kidney Int. 68, 1289\u20131293 (2005).","journal-title":"Kidney Int."},{"key":"BFnrcardio200911_CR81","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1001\/archinte.160.8.1093","volume":"160","author":"CT Valmadrid","year":"2000","unstructured":"Valmadrid, C. T., Klein, R., Moss, S. E. & Klein, B. E. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch. Intern. Med. 160, 1093\u20131100 (2000).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio200911_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0002-9343(00)00444-7","volume":"109","author":"BF Culleton","year":"2000","unstructured":"Culleton, B. F., Larson, M. G., Parfrey, P. S., Kannel, W. B. & Levy, D. Proteinuria as a risk factor for cardiovascular disease and mortality in older people: a prospective study. Am. J. Med. 109, 1\u20138 (2000).","journal-title":"Am. J. Med."},{"key":"BFnrcardio200911_CR83","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/sj.ki.5000284","volume":"69","author":"F Irie","year":"2006","unstructured":"Irie, F.  et al. The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. Kidney Int. 69, 1264\u20131271 (2006).","journal-title":"Kidney Int."},{"key":"BFnrcardio200911_CR84","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1001\/archinte.166.8.884","volume":"166","author":"JR Madison","year":"2006","unstructured":"Madison, J. R.  et al. Proteinuria and risk for stroke and coronary heart disease during 27 years of follow-up. Arch. Int. Med. 166, 884\u2013889 (2006).","journal-title":"Arch. Int. Med."},{"key":"BFnrcardio200911_CR85","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1093\/ndt\/gfm051","volume":"22","author":"M Nakayama","year":"2007","unstructured":"Nakayama, M.  et al. Kidney dysfunction as a risk factor for first symptomatic stroke events in a general Japanese population\u2014the Ohasama study. Nephrol. Dial. Transplant. 22, 1910\u20131915 (2007).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrcardio200911_CR86","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1053\/j.ajkd.2006.04.077","volume":"48","author":"M MacKinnon","year":"2006","unstructured":"MacKinnon, M.  et al. Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data. Am. J. Kidney Dis. 48, 8\u201320 (2006).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrcardio200911_CR87","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1046\/j.1523-1755.1998.00083.x","volume":"54","author":"GL Bakris","year":"1998","unstructured":"Bakris, G. L., Weir, M. R., DeQuattro, V. & McMahon, F. G. Effects of an ACE inhibitor\/calcium antagonist combination on proteinuria in diabetic nephropathy. Kidney Int. 54, 1283\u20131289 (1998).","journal-title":"Kidney Int."},{"key":"BFnrcardio200911_CR88","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1681\/ASN.2006121372","volume":"18","author":"FF Hou","year":"2007","unstructured":"Hou, F. F.  et al. Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study: a randomized controlled study of benazepril and losartan in chronic renal insufficiency. J. Am. Soc. Nephrol. 18, 1889\u20131898 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrcardio200911_CR89","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1053\/j.ajkd.2005.08.034","volume":"46","author":"P Aranda","year":"2005","unstructured":"Aranda, P.  et al. Long-term renoprotective effects of standard versus high doses of telmisartan in hypertensive nondiabetic nephropathies. Am. J. Kidney Dis. 46, 1074\u20131079 (2005).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrcardio200911_CR90","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1038\/sj.ki.5001854","volume":"70","author":"S Bianchi","year":"2006","unstructured":"Bianchi, S., Bigazzi, R. & Campese, V. M. Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease. Kidney Int. 70, 2116\u20132123 (2006).","journal-title":"Kidney Int."},{"key":"BFnrcardio200911_CR91","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1111\/j.1523-1755.2005.00756.x","volume":"68","author":"KJ Schjoedt","year":"2005","unstructured":"Schjoedt, K. J.  et al. Beneficial impact of spironolactone in diabetic nephropathy. Kidney Int. 68, 2829\u20132836 (2005).","journal-title":"Kidney Int."},{"key":"BFnrcardio200911_CR92","doi-asserted-by":"publisher","first-page":"256","DOI":"10.2215\/CJN.01040905","volume":"1","author":"A Chrysostomou","year":"2006","unstructured":"Chrysostomou, A., Pedagogos, E., MacGregor, L. & Becker, G. J. Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker. Clin. J. Am. Soc. Nephrol. 1, 256\u2013262 (2006).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrcardio200911_CR93","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1056\/NEJMoa0708379","volume":"358","author":"HH Parving","year":"2008","unstructured":"Parving, H. H.  et al. Aliskiren combined with losartan in type 2 diabetes and nephropathy. N. Engl. J. Med. 358, 2433\u20132446 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio200911_CR94","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1053\/j.ajkd.2008.01.014","volume":"51","author":"JC Ansquer","year":"2008","unstructured":"Ansquer, J. C.  et al. Effect of fenofibrate on kidney function: a 6-week randomized crossover trial in healthy people. Am. J. Kidney Dis. 51, 904\u2013913 (2008).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrcardio200911_CR95","doi-asserted-by":"publisher","first-page":"200S","DOI":"10.1016\/S0895-7061(96)00392-5","volume":"9","author":"GL Bakris","year":"1996","unstructured":"Bakris, G. L. & Weir, M. R. Salt intake and reductions in arterial pressure and proteinuria. Is there a direct link? Am. J. Hypertens. 9, 200S\u2013206S (1996).","journal-title":"Am. J. Hypertens."},{"key":"BFnrcardio200911_CR96","doi-asserted-by":"publisher","first-page":"201","DOI":"10.7326\/0003-4819-125-3-199608010-00007","volume":"125","author":"GL Bakris","year":"1996","unstructured":"Bakris, G. L. & Smith, A. Effects of sodium intake on albumin excretion in patients with diabetic nephropathy treated with long-acting calcium antagonists. Ann. Intern. Med. 125, 201\u2013204 (1996).","journal-title":"Ann. Intern. Med."},{"key":"BFnrcardio200911_CR97","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/ki.1989.190","volume":"36","author":"JE Heeg","year":"1989","unstructured":"Heeg, J. E., de Jong, P. E., van der Hem, G. K. & de Zeeuw, D. Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int. 36, 272\u2013279 (1989).","journal-title":"Kidney Int."},{"key":"BFnrcardio200911_CR98","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1093\/ndt\/13.7.1682","volume":"13","author":"H Buter","year":"1998","unstructured":"Buter, H., Hemmelder, M. H., Navis, G., de Jong, P. E. & de Zeeuw, D. The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide. Nephrol. Dial. Transplant. 13, 1682\u20131685 (1998).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrcardio200911_CR99","first-page":"F1083","volume":"253","author":"ME Rosenberg","year":"1987","unstructured":"Rosenberg, M. E., Swanson, J. E., Thomas, B. L. & Hostetter, T. H. Glomerular and hormonal responses to dietary protein intake in human renal disease. Am. J. Physiol. 253, F1083\u2013F1090 (1987).","journal-title":"Am. J. Physiol."},{"key":"BFnrcardio200911_CR100","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1093\/ajcn\/88.3.660","volume":"88","author":"Y Pan","year":"2008","unstructured":"Pan, Y., Guo, L. L. & Jin, H. M. Low-protein diet for diabetic nephropathy: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 88, 660\u2013666 (2008).","journal-title":"Am. J. Clin. Nutr."},{"key":"BFnrcardio200911_CR101","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1053\/j.ajkd.2008.08.009","volume":"53","author":"V Menon","year":"2009","unstructured":"Menon, V.  et al. Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am. J. Kidney Dis. 53, 208\u2013217 (2009).","journal-title":"Am. J. Kidney Dis."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2009.11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2009.11","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2009.11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T08:20:53Z","timestamp":1650356453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2009.11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":101,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["BFnrcardio200911"],"URL":"https:\/\/doi.org\/10.1038\/nrcardio.2009.11","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}